ELUT (Elutia Inc. Class A Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by ELUT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | C Randal Mills | PRESIDENT AND CEO | MIXED | — | — |
| 2026-06-15 | David Colpman | Director | A | — | — |
| 2026-06-15 | GUIDO J NEELS | Director | A | — | — |
| 2026-06-15 | Brigid Makes | Director | A | — | — |
| 2026-06-15 | KEVIN RAKIN | Director | A | — | — |
| 2026-06-12 | Matthew Ferguson | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-06-12 | Michelle LeRoux Williams | CHIEF SCIENTIFIC OFFICER | MIXED | — | — |
| 2026-06-12 | C Randal Mills | PRESIDENT AND CEO | MIXED | — | — |
| 2026-06-02 | HighCape Partners QP II, L.P. | 10%+ Owner | MIXED | — | — |
| 2026-04-14 | GUIDO J NEELS | Director | M | — | — |
| 2026-03-12 | C Randal Mills | PRESIDENT AND CEO | MIXED | — | — |
| 2026-03-12 | Michelle LeRoux Williams | CHIEF SCIENTIFIC OFFICER | MIXED | — | — |
| 2026-03-12 | Matthew Ferguson | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-02-02 | GUIDO J NEELS | Director | Buy | — | — |
| 2026-02-02 | KEVIN RAKIN | Director | Buy | — | — |
| 2026-01-29 | GUIDO J NEELS | Director | Buy | — | — |
| 2026-01-05 | Michelle LeRoux Williams | CHIEF SCIENTIFIC OFFICER | A | — | — |
| 2026-01-05 | Matthew Ferguson | CHIEF FINANCIAL OFFICER | A | — | — |
| 2026-01-05 | C Randal Mills | PRESIDENT AND CEO | A | — | — |
| 2025-12-19 | HighCape Partners GP II, LLC | 10%+ Owner | Buy | — | — |
| 2025-12-19 | HIGHCAPE PARTNERS QP, L.P. | 10%+ Owner | J | — | — |
| 2025-12-18 | C Randal Mills | PRESIDENT AND CEO | Buy | — | — |
| 2025-12-18 | Matthew Ferguson | CHIEF FINANCIAL OFFICER | Buy | — | — |
| 2025-12-18 | Brigid Makes | Director | Buy | — | — |
| 2025-12-18 | David Colpman | Director | Buy | — | — |
| 2025-12-17 | KEVIN RAKIN | Director | J | — | — |
| 2025-12-15 | KEVIN RAKIN | Director | J | — | — |
| 2025-12-12 | C Randal Mills | PRESIDENT AND CEO | MIXED | — | — |
| 2025-12-12 | Michelle LeRoux Williams | CHIEF SCIENTIFIC OFFICER | MIXED | — | — |
| 2025-12-12 | Matthew Ferguson | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2025-12-03 | Matthew Ferguson | CHIEF FINANCIAL OFFICER | Buy | — | — |
| 2025-12-02 | GUIDO J NEELS | Director | M | — | — |
| 2025-11-26 | C Randal Mills | PRESIDENT AND CEO | Buy | — | — |
| 2025-11-19 | David Colpman | Director | Buy | — | — |
| 2025-11-14 | C Randal Mills | PRESIDENT AND CEO | Buy | — | — |
| 2025-10-14 | GUIDO J NEELS | Director | A | — | — |
| 2025-09-11 | Matthew Ferguson | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2025-09-11 | Michelle LeRoux Williams | CHIEF SCIENTIFIC OFFICER | MIXED | — | — |
| 2025-09-11 | C Randal Mills | PRESIDENT AND CEO | MIXED | — | — |
| 2025-06-24 | C Randal Mills | PRESIDENT AND CEO | MIXED | — | — |
| 2025-06-12 | Matthew Ferguson | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2025-06-12 | Michelle LeRoux Williams | CHIEF SCIENTIFIC OFFICER | MIXED | — | — |
| 2025-06-12 | C Randal Mills | PRESIDENT AND CEO | MIXED | — | — |
| 2025-06-02 | Maybelle Jordan | Director | A | — | — |
| 2025-06-02 | Matt Zuga | Director | A | — | — |
| 2025-06-02 | KEVIN RAKIN | Director | A | — | — |
| 2025-06-02 | Brigid Makes | Director | A | — | — |
| 2025-06-02 | David Colpman | Director | A | — | — |
| 2025-03-13 | HighCape Capital, L.P. | Director | Buy | — | — |
| 2025-03-13 | HighCape Partners GP, LLC | 10%+ Owner | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 9,520,232 | — |
| — | Director | 9,520,232 | — |
| — | 10%+ Owner | 9,100,232 | — |
| — | 10%+ Owner | 6,998,655 | — |
| — | 10%+ Owner | 6,998,655 | — |
| — | 10%+ Owner | 5,105,098 | — |
| — | 10%+ Owner | 4,832,679 | — |
| — | 10%+ Owner | 4,832,679 | — |
| — | — | 1,615,184 | — |
| — | Director | 518,539 | — |
| — | CHIEF FINANCIAL OFFICER | 480,082 | — |
| — | PRESIDENT AND CEO | 449,244 | — |
| — | Director | 125,000 | — |
| — | CHIEF SCIENTIFIC OFFICER | 118,052 | — |
| — | Director | 31,098 | — |
| — | Director | 27,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ELUT quote page; the site-wide leaderboard is on the insider transactions hub.